ELAN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Elanco Animal Health Inc (ELAN) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong Q4 financial performance, positive analyst sentiment, and bullish technical indicators suggest a promising growth trajectory. Despite minor short-term price fluctuations, the long-term outlook is favorable.
The stock's MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 61.428, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are at S1: 23.946, Pivot: 25.547, and R1: 27.147, suggesting the stock is trading near support levels with potential upside.
Strong Q4 2025 financial results with 12% YoY revenue growth and raised FY26 revenue guidance.
Analysts have consistently raised price targets, with most now at $30, reflecting confidence in the company's growth potential.
Bullish technical indicators and moving averages.
Net loss of $276 million in Q4 2025, indicating operational challenges.
Slightly bearish sentiment in options data, with a Put-Call ratio above
Short-term price trend shows a potential minor decline in the next week or month.
Elanco reported Q4 2025 revenue of $1.14 billion, up 12% YoY, and full-year revenue of $4.7 billion, up ~6% YoY. Despite a net loss of $276 million, gross margin improved to 39.34%, up 3.15% YoY, showing operational efficiency gains.
Analysts are highly optimistic, with multiple firms raising price targets to $30 and maintaining Buy or Overweight ratings. Analysts highlight strong Q4 performance, growth across all segments, and confidence in innovative product pipelines.
